InsiderTrades

Form 4 for AXGN Axogen, Inc.

Accepted 2022-12-28 00:00:00 ET · period of report 2022-12-27 · accession 0000805928-22-000133 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-28 2022-12-27 AXGN DeVinney Erick Wayne VP Peripheral Nerve Science M - OptEx $5.09 +20.0K 116.8K +21% +$101.8K
D 2022-12-28 2022-12-27 AXGN DeVinney Erick Wayne VP Peripheral Nerve Science F - Tax $9.44 -10.8K 106.0K -9% -$101.8K
D 2022-12-28 2022-12-27 AXGN DeVinney Erick Wayne VP Peripheral Nerve Science M - OptEx $0.00 -20.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-27 M A 20,000 $5.09 116,752 D — — (F1) This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock, the Reporting Person, on a net basis, acquired ownership of an additional 9,216 shares of common stock.
2 Common Common Stock 2022-12-27 F D 10,784 $9.44 105,968 D — — (F1) This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock, the Reporting Person, on a net basis, acquired ownership of an additional 9,216 shares of common stock.
3 Derivative Employee Stock Option (right to buy) 2022-12-27 M D 20,000 $0.00 0 D $5.09 · 2016-12-28 to 2022-12-28 20,000 Common Stock